Lauren Averett Byers, MD, MS
机构: MD Anderson Cancer Center
每年引用次数
引用次数
引用: 40,634
H-指数: 75
I10-指数 : 171
出版物: 489
First-in-human trial of novel oral PARP inhibitor BMN 673 in patients with solid tumors
Johann Sebastian De Bono , Lida A. Mina , Michael Gonzalez , Nicola J. Curtin
Journal of Clinical Oncology 31 2580 -2580
58
2013
Evading the STING: LKB1 Loss Leads to STING Silencing and Immune Escape in KRAS-Mutant Lung Cancers.
Carminia Maria Della Corte , Lauren Averett Byers
Cancer Discovery 9 ( 1) 16 -18
9
2019
Temozolomide plus PARP Inhibition in Small-Cell Lung Cancer: Could Patient-Derived Xenografts Accelerate Discovery of Biomarker Candidates?
Jose M. Pacheco , Lauren Averett Byers
Cancer Discovery 9 ( 10) 1340 -1342
1
2019
Phase I, dose-escalation, two-part trial of the PARP inhibitor talazoparib in patients with advanced germline BRCA1/2 mutations and selected sporadic cancers
Johann de Bono , Ramesh K Ramanathan , Lida Mina , Rashmi Chugh
Cancer Discovery 7 ( 6) 620 -629
341
2017
CD38-mediated immunosuppression as a mechanism of tumor cell escape from PD-1/PD-l1 blockade
Limo Chen , Lixia Diao , Yongbin Yang , Xiaohui Yi
Cancer Discovery 8 ( 9) 1156 -1175
298
2018
Selecting Reliable mRNA Expression Measurements Across Platforms Improves Downstream Analysis.
Pan Tong , Lixia Diao , Li Shen , Lerong Li
Cancer Informatics 15 ( 15) 81 -89
1
2016
Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data.
Charles M Rudin , John T Poirier , Lauren Averett Byers , Caroline Dive
Nature Reviews Cancer 19 ( 5) 289 -297
581
2019
Durable, exceptional response to temozolomide in a patient with extensive-stage small cell lung cancer (ES-SCLC) metastatic to brain
Carl M. Gay , Patricia M. de Groot , M. Catherine Pietanza , Lauren Averett Byers
Cancer treatment and research 10 17 -20
3
2017
Small-cell lung cancer: Treatment of extensive-stage disease
Lauren Averett Byers , John V Heymach ,
Personalized Management of Lung Cancer 142 -158
2013
Serum Signature of Hypoxia-Regulated Factors Is Associated with Progression after Induction Therapy in Head and Neck Squamous Cell Cancer
Lauren Averett Byers , F Christopher Holsinger , Merrill S Kies , William N William
Molecular Cancer Therapeutics 9 ( 6) 1755 -1763
39
2010
ILK and SHP2 expression identify a poor prognostic cohort of EGFR-mutant lung cancer.
Carminia Maria Della Corte , Carl Michael Gay , Lauren Averett Byers , Floriana Morgillo
EBioMedicine 39 5 -6
2
2019
Proteomic Profiling Identifies Pathways Dysregulated in Non-small Cell Lung Cancer and an Inverse Association of AMPK and Adhesion Pathways with Recurrence
Meera Nanjundan , Lauren Averett Byers , Mark S. Carey , Doris R. Siwak
Journal of Thoracic Oncology 5 ( 12) 1894 -1904
69
2010
An Epithelial–Mesenchymal Transition Gene Signature Predicts Resistance to EGFR and PI3K Inhibitors and Identifies Axl as a Therapeutic Target for Overcoming EGFR Inhibitor Resistance
Lauren Averett Byers , Lixia Diao , Jing Wang , Pierre Saintigny
Clinical Cancer Research 19 ( 1) 279 -290
583
2013
Proteomic Profiling Identifies Dysregulated Pathways in Small Cell Lung Cancer and Novel Therapeutic Targets Including PARP1
Lauren Averett Byers , Jing Wang , Monique B. Nilsson , Junya Fujimoto
Cancer Discovery 2 ( 9) 798 -811
290
2012
Teaching an old dog new tricks: drug repositioning in small cell lung cancer.
Jing Wang , Lauren Averett Byers
Cancer Discovery 3 ( 12) 1333 -1335
17
2013
A HER 1-2 Punch: Dual EGFR Targeting Deals Resistance a Deadly Blow
Don L. Gibbons , Lauren Averett Byers
Cancer Discovery 4 ( 9) 991 -994
6
2014
Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor Resistance
George N Naumov , Monique B Nilsson , Tina Cascone , Alexandra Briggs
Clinical Cancer Research 15 ( 10) 3484 -3494
342
2009
Reciprocal regulation of c-Src and STAT3 in non-small cell lung cancer.
Lauren Averett Byers , Banibrata Sen , Babita Saigal , Lixia Diao
Clinical Cancer Research 15 ( 22) 6852 -6861
80
2009
Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology
C Allison Stewart , Carl M Gay , Kavya Ramkumar , Kasey R Cargill
bioRxiv
6
2021
CHK1 Inhibition in Small-Cell Lung Cancer Produces Single-Agent Activity in Biomarker-Defined Disease Subsets and Combination Activity with Cisplatin or Olaparib
Triparna Sen , Pan Tong , C. Allison Stewart , Sandra Cristea
Cancer Research 77 ( 14) 3870 -3884
87
2017